This HTML5 document contains 141 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34293506
rdf:type
wikibase:Item
schema:description
scienca artikolo artikulong pang-agham мақолаи илмӣ επιστημονικό άρθρο 2004 թվականի փետրվարին հրատարակված գիտական հոդված vedecký článok tudományos cikk 2004年论文 artículu científicu espublizáu en 2004 2004年論文 bilimsel makale mokslinis straipsnis bài báo khoa học vitenskapelig artikkel vetenskaplig artikel wissenschaftlicher Artikel videnskabelig artikel (udgivet 2004) 2004年論文 научни чланак ২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ מאמר מדעי سائنسی مضمون tieteellinen artikkeli wetenschappelijk artikel article científic სამეცნიერო სტატია 2004年论文 2004 nî lūn-bûn научна статия artigo científico (publicado na 2004) artigo científico (publicado na 2004) articolo scientifico 2004年论文 2004年論文 научни чланак artigo científico naučni članak vědecký článek 2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած article scientific 2004年论文 บทความทางวิทยาศาสตร์ artikull shkencor مقالهٔ علمی наукова стаття, опублікована в лютому 2004 scientific article 2004年论文 artículo científico publicado en 2004 2004年の論文 научная статья 2004年論文 artykuł naukowy мақолаи илмӣ articol științific 2004년 논문 teaduslik artikkel 2004年論文 vitskapeleg artikkel article scientifique (publié 2004) 2004年论文 مقالة علمية
p:P577
wds:Q34293506-D199971E-4D12-4E22-8D12-B84526819EA4
wdt:P577
2004-02-01T00:00:00Z
p:P2860
wds:Q34293506-64262E4E-F678-433C-8D94-DB8E779F15B7 wds:Q34293506-6684E6E5-F8B8-42C5-BEFF-BBE2A8CCC503 wds:Q34293506-3BE3C6BB-70FC-406E-90FC-4A2D8BB4297E wds:Q34293506-2546EA21-AE30-440D-A501-46853A7771C6 wds:Q34293506-348DB19B-3D64-4B4F-9B39-DA401AD6867D wds:Q34293506-1E98E844-F85C-4640-BAE8-3FCA1B2151C5 wds:Q34293506-22A33E89-2A47-4AE2-8089-DE82CA506310 wds:Q34293506-DE13F97D-42C7-44EC-8AC8-B671BDE9EDA6 wds:Q34293506-E2E26A12-FEFC-44A3-8C26-88F6F32418CE wds:Q34293506-A72719FD-CA84-4D53-92AE-9DD84ECDF75C wds:Q34293506-9CAD65D7-D27B-4F66-93F9-924F23BED36D wds:Q34293506-7789743E-D85B-4CA6-BB2B-015D83B2678F wds:Q34293506-77E7137B-06B1-4744-AC8A-9C5786FF3BA1
wdt:P2860
wd:Q44120544 wd:Q24561842 wd:Q36767887 wd:Q34867708 wd:Q34150579 wd:Q34759244 wd:Q33963261 wd:Q40702262 wd:Q77425807 wd:Q28203143 wd:Q34624139 wd:Q78306567 wd:Q29617440
p:P2093
wds:Q34293506-E9FF765F-4363-48FB-9D71-9FC1440BF2A1 wds:Q34293506-82F4A20F-F430-4320-AC37-89617031459E wds:Q34293506-88B94751-49D2-4421-99C6-518A47032987 wds:Q34293506-A23DF829-A8D6-42AE-90C4-B425569C6BF5 wds:Q34293506-A57C33E8-E382-4C99-90B8-783608FA76C8 wds:Q34293506-456250CF-0AE2-4AC3-8A39-807EFE2ECC4B wds:Q34293506-35D4A8F9-EF71-40F3-A8FD-3CC56FCD31A4 wds:Q34293506-03753A30-E2D7-4374-8547-E2758270427F
wdt:P2093
Timothy Kute Kathy Barrett Christopher M Lack James P Vaughn Holly Williams Mark Willingham Bimjhana Bishwokama Tanita Mitchell
rdfs:label
Development of Herceptin resistance in breast cancer cells Development of Herceptin resistance in breast cancer cells Development of Herceptin resistance in breast cancer cells
skos:prefLabel
Development of Herceptin resistance in breast cancer cells Development of Herceptin resistance in breast cancer cells Development of Herceptin resistance in breast cancer cells
schema:name
Development of Herceptin resistance in breast cancer cells Development of Herceptin resistance in breast cancer cells Development of Herceptin resistance in breast cancer cells
p:P1476
wds:Q34293506-F206FF18-28DA-47F2-9C22-F53B98F017C8
wdt:P1476
Development of Herceptin resistance in breast cancer cells
p:P304
wds:Q34293506-249BF653-387F-4EA0-B232-3B471BD78F80
wdt:P304
86-93
p:P31
wds:Q34293506-F533E974-D7A5-475F-93A2-C562B30F59C3
wdt:P31
wd:Q13442814
p:P921
wds:Q34293506-9548666C-B584-4BAE-A0AD-B10EA5711372 wds:Q34293506-54DBB505-F9C4-4FD3-B063-7FF253417826
wdt:P921
wd:Q21014462 wd:Q128581
p:P698
wds:Q34293506-A6B68290-9D6D-4713-978F-D66CBEFE8603
wdtn:P698
n10:14750129
wdt:P698
14750129
p:P1433
wds:Q34293506-DD7EB51E-48BD-4877-AE7D-04B92204EABF
wdt:P1433
wd:Q15764023
p:P433
wds:Q34293506-56B2A87A-18B6-4E5A-90F1-D5B1DBD66D62
p:P478
wds:Q34293506-BD29999F-C830-4DC5-B97B-CD2EBE70711D
wdt:P433
2
wdt:P478
57
p:P356
wds:Q34293506-62AB641A-4780-4A68-A179-3CCDBD22DF6C
wdtn:P356
n12:CYTO.A.10095
wdt:P356
10.1002/CYTO.A.10095
p:P5875
wds:Q34293506-2C058E30-89F3-4BE5-B863-7282C6A553AE
wdt:P5875
8897394
p:P4510
wds:Q34293506-D9C4FB52-9E17-4677-8D6E-DF55F691AF71
wdt:P4510
wd:Q54798462